Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC in Germany
Germany: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 92.0% in 2025. ▲ Rising
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Germany, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Germany recorded 92.0% for measles-containing-vaccine second-dose (mcv2) immunization coverage in 2025.
Compared with earlier readings it is down 1.1% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Germany peaked at 93.0% in 2009 and was at its lowest, 0.0%, in 2000.
Germany ranks 56th of 194 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 26 years of available data.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Germany, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 77.0% | — |
| 2003 | 83.0% | +7.8% |
| 2004 | 89.0% | +7.2% |
| 2005 | 91.0% | +2.2% |
| 2006 | 90.0% | -1.1% |
| 2007 | 92.0% | +2.2% |
| 2008 | 92.0% | +0.0% |
| 2009 | 93.0% | +1.1% |
| 2010 | 93.0% | +0.0% |
| 2011 | 93.0% | +0.0% |
| 2012 | 93.0% | +0.0% |
| 2013 | 93.0% | +0.0% |
| 2014 | 93.0% | +0.0% |
| 2015 | 93.0% | +0.0% |
| 2016 | 93.0% | +0.0% |
| 2017 | 93.0% | +0.0% |
| 2018 | 93.0% | +0.0% |
| 2019 | 93.0% | +0.0% |
| 2020 | 93.0% | +0.0% |
| 2021 | 93.0% | +0.0% |
| 2022 | 90.0% | -3.2% |
| 2023 | 91.0% | +1.1% |
| 2024 | 92.0% | +1.1% |
| 2025 | 92.0% | +0.0% |
Germany compared with similar countries
- Germany's 92.0% is above the median for high income countries, which is 92.0%, 1.0× the median. (63 countries reporting)
- Germany's 92.0% is above the median for Europe & Central Asia, which is 90.0%, 1.0× the median. (51 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 70.7% | 0.0% | 93.0% | 10 |
| 2010s | 93.0% | 93.0% | 93.0% | 10 |
| 2020s | 91.8% | 90.0% | 93.0% | 6 |
Countries ranked near Germany
More health data for Germany
- Un projection of annual infant deaths, annual growth rate -2.13 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.9955 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,164 deaths per 1,000 people (2090)
- Number of infants who die before age 1 368 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2000)
- Population ages 00-04, female, annual growth rate -2.18 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0216 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.2 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Germany?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Germany was 92.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Germany?
- The highest recorded value was 93.0% in 2009.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Germany?
- The lowest recorded value was 0.0% in 2000.
- How does Germany rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Germany ranks 56th out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Germany?
- Over the last ten years it is down 1.1%. The long-run trend across the full record is rising.
- Where does this Germany data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).